Healthcare -
Biotechnology - NASDAQ - GB
$ 2.715
-3.53 %
$ 432 M
Market Cap
-7.03
P/E
MREO - CASH FROM OPERATIONS
Cash from Operations MREO - Mereo BioPharma Group plc
-32.8 M
LAST VALUE
8.03%
2 YEAR CAGR
6.49%
5 YEAR CAGR
0.00%
10 YEAR CAGR